In the context of Alzheimer's disease, Aβ peptides aggregate to form extracellular amyloid plaques in the brain. These plaques disrupt cell function and are associated with neuronal death. The accumulation of Aβ peptides triggers a cascade of biochemical events, leading to inflammation, oxidative stress, and tau pathology, ultimately contributing to cognitive decline.
